Keith Katkin

(Mr. Keith Katkin CPA)

Currently holds a position at Syndax Pharmaceuticals Inc

Positions
Position Company Period
Independent Director Syndax Pharmaceuticals Inc March 29, 2017 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Total value Details
Oct. 7, 2022 Oct. 6, 2022
PS Planned sale
9,117 -22.2%
25.90
236,139 USD
9,117 -22.2% 25.90 236,139 USD
Oct. 7, 2022 Oct. 6, 2022
PS Planned sale
20,782 -39.4%
25.90
538,273 USD
20,782 -39.4% 25.90 538,273 USD
Oct. 4, 2022 Oct. 4, 2022
PS Planned sale
223 -0.7%
25.00
5,575 USD
223 -0.7% 25.00 5,575 USD
Oct. 4, 2022 Oct. 4, 2022
PS Planned sale
137 -0.4%
25.00
3,425 USD
137 -0.4% 25.00 3,425 USD
Oct. 4, 2022 Oct. 3, 2022
PS Planned sale
13 -0.0%
25.00
325 USD
13 -0.0% 25.00 325 USD
Oct. 4, 2022 Oct. 3, 2022
PS Planned sale
167 -0.5%
25.00
4,175 USD
167 -0.5% 25.00 4,175 USD
Oct. 4, 2022 Sept. 30, 2022
PS Planned sale
647 -2.0%
25.07
16,221 USD
647 -2.0% 25.07 16,221 USD
Oct. 4, 2022 Sept. 30, 2022
PS Planned sale
2,914 -8.3%
25.07
73,056 USD
2,914 -8.3% 25.07 73,056 USD